🏥 Health Nov 14, 2022

Experimental therapy gantenerumab fails to slow or improve Alzheimer's memory loss in clinical trials

CNN Health
View Channel →
Source ↗ 👁 18 💬 0
An experimental treatment, gantenerumab, failed to help people at high risk of memory loss from Alzheimer's or those who were in the early phases of the disease, the manufacturer said Monday.

Comments (0)

Sign in to join the discussion

More Like This

📰
More REM sleep linked to lower risk of 83 diseases
Health & Medicine News -- ScienceDaily · 1d ago
📰
GLP-1 weight loss and diabetes drugs linked to nutritional deficiencies in nearly 1 in 6 children
Health & Medicine News -- ScienceDaily · 1d ago
White House plan to increase control of NIH grants appears ‘dead’
STAT · 1d ago
Menopausal Hormone Therapy Thrombotic Risk Varies by Dose, Route of Administration
MedPageToday.com - medical news for physicians · 1d ago
STAT+: Nominee to lead FDA aims to speed up medical research, combat China’s rise
STAT · 1d ago
📰
Gifts from Friends provides thoughtful way to celebrate
Vanderbilt Health News · 1d ago